Method for in vitro mass proliferation and culturing of vδ1 t cells without need for artificial antigen-presenting cells
WO2025220807A1PCT designated stage Publication Date: 2025-10-23BIO SOLUTION CO LTD
-1 Cites -1 Cited by
Patent Information
- Application Number
- PCT/KR2024/012099
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-04-15
- Filing Date
- 2024-08-14
- Publication Date
- 2025-10-23
Smart Images

Figure KR2024012099_23102025_PF_FP_ABST
Abstract
The present invention relates to a method for mass proliferation and culturing of Vδ1 T cells, Vδ1 T cells produced by the method, and a use thereof, the method comprising a step for activating lymphocytes from a biological sample containing the lymphocytes, a step for isolating Vδ1 T cells from the activated cell population, and a step for proliferating and culturing the isolated Vδ1 T cells by treating the isolated Vδ1 T cells with an anti-TCRVδ1 antibody. The method for mass proliferation and culturing according to the present invention makes it possible to produce Vδ1 T cells without artificial antigen-presenting cells, while maintaining an excellent proliferation rate and purity, and thus can be effectively used in related technical fields such as cancer treatment using Vδ1 T cells.
Need to check novelty before this filing date? Find Prior Art